Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.
The most recent EPS for Universe Pharmaceuticals Inc is $, expectations of $.
How did Universe Pharmaceuticals Inc UPC's revenue perform in the last quarter?
Universe Pharmaceuticals Inc revenue for the last quarter is $
What is the revenue estimate for Universe Pharmaceuticals Inc?
According to of Wall street analyst, the revenue estimate of Universe Pharmaceuticals Inc range from $ to $
What's the earning quality score for Universe Pharmaceuticals Inc?
Universe Pharmaceuticals Inc has a earning quality score of B+/52.835266. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Universe Pharmaceuticals Inc report earnings?
Universe Pharmaceuticals Inc next earnings report is expected in 2026-04-29
What are Universe Pharmaceuticals Inc's expected earnings?
Universe Pharmaceuticals Inc expected earnings is $, according to wall-street analysts.
Did Universe Pharmaceuticals Inc beat earnings expectations?
Universe Pharmaceuticals Inc recent earnings of $ expectations.